As hospitals and physician reimbursement becomes increasingly tied to outcomes, how we manage patients at greater risk of complications becomes paramount. In this session, we discuss risk mitigation strategies and the role of surgical policies to limit infection and revision rate.
Upon completion of this educational activity, participants should be able to:
- Review outcomes on patients on high dose opioids.
- Discuss the ethics surrounding saying no to patients.
- Describe risk mitigation strategies in difficult patient populations.
- Indicate how to avoid complications in neuromodulation patients.
Identifying the High-Risk Patients: Strategies for Neuromodulators
Julie G. Pilitsis, MD PhD
When Hospitals Say No: Limiting Elective Surgery on Patients With BMI Over 35
Ajit A. Krishnaney, MD
The Ethics of Saying No to Surgery in Patients
Megan K. Applewhite, MD MA FACS
B. Todd Sitzman, MD MPH
Faculty and Presentations subject to change.
- Thematic Abstract Presentations
- Plenary Session I -- What We Have Learned About Placebo: Implications for Clinical Practice and the Interpretation of Evidence About Analgesics
- Emerging Indications for Deep Brain Stimulation
- Practice Development
- Advancing Pain Management Science and Education: ASRA Special Session